MX2009000506A - Composiciones y metodos para el tratamiento de la mucormicosis y otras enfermedades micoticas. - Google Patents
Composiciones y metodos para el tratamiento de la mucormicosis y otras enfermedades micoticas.Info
- Publication number
- MX2009000506A MX2009000506A MX2009000506A MX2009000506A MX2009000506A MX 2009000506 A MX2009000506 A MX 2009000506A MX 2009000506 A MX2009000506 A MX 2009000506A MX 2009000506 A MX2009000506 A MX 2009000506A MX 2009000506 A MX2009000506 A MX 2009000506A
- Authority
- MX
- Mexico
- Prior art keywords
- antifungal agent
- iron chelating
- fungal condition
- chelating compound
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención proporciona una composición que incluye al menos un compuesto quelante del hierro y al menos un agente antimicótico; la composición puede incluir los compuestos quelantes del hierro deferiprona o deferasirox; un agente antimicótico incluido en la composición puede incluir un agente antimicótico de polieno, un agente antimicótico de azol o un agente antimicótico de equinocandina; la invención también proporciona un método para tratar o prevenir una condición micótica; el método incluye administrar a un individuo que tiene, o es susceptible de tener una condición micótica, una cantidad terapéuticamente efectiva de al menos un compuesto quelante del hierro, durante un tiempo suficiente para reducir la severidad de una condición micótica, en donde el compuesto quelante del hierro comprende un no sideróforo o un no xenosideróforo, con relación a la condición micótica; un método para tratar o prevenir una condición micótica, proporcionado por la invención, también puede incluir administrar a un individuo que tiene, o que es susceptible de tener una condición micótica, una cantidad terapéuticamente efectiva de al menos un compuesto quelante del hierro y al menos un agente antimicótico; se proporciona además por la invención, un método que incluye la administración profiláctica de al menos un compuesto quelante del hierro o al menos un compuesto quelante del hierro y al menos un agente antimicótico, antes del inicio de la condición micótica.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83109906P | 2006-07-13 | 2006-07-13 | |
US89762007P | 2007-01-26 | 2007-01-26 | |
US90407507P | 2007-02-27 | 2007-02-27 | |
PCT/US2007/016065 WO2008008537A2 (en) | 2006-07-13 | 2007-07-13 | Combi) compositions for the treatment of mucormycosis. comprising iron chelator and antifungal agent |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009000506A true MX2009000506A (es) | 2009-05-20 |
Family
ID=38610625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009000506A MX2009000506A (es) | 2006-07-13 | 2007-07-13 | Composiciones y metodos para el tratamiento de la mucormicosis y otras enfermedades micoticas. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20100129434A1 (es) |
EP (2) | EP2412371A1 (es) |
JP (2) | JP2009543788A (es) |
KR (1) | KR20090036587A (es) |
AU (1) | AU2007272781B2 (es) |
BR (1) | BRPI0714221A2 (es) |
CA (1) | CA2657634A1 (es) |
CL (1) | CL2007002026A1 (es) |
IL (1) | IL196389A0 (es) |
MA (1) | MA30625B1 (es) |
MX (1) | MX2009000506A (es) |
NO (1) | NO20090565L (es) |
NZ (1) | NZ574862A (es) |
RU (1) | RU2464024C2 (es) |
SG (1) | SG177122A1 (es) |
TN (1) | TN2009000004A1 (es) |
TW (1) | TWI448285B (es) |
WO (1) | WO2008008537A2 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ614255A (en) * | 2009-03-19 | 2015-03-27 | Los Angeles Biomed Res Inst | Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
US8980876B2 (en) | 2010-10-28 | 2015-03-17 | The Procter & Gamble Company | Inhibition of microbial growth by aconitase inhibition |
JP2015536970A (ja) * | 2012-11-12 | 2015-12-24 | シプラ・リミテッド | デフェラシロクス及びデフェリプロンを含む固定用量医薬組成物 |
WO2014120774A1 (en) | 2013-01-29 | 2014-08-07 | Case Western Reserve University | Fungal iron acquisition inhibitors and uses thereof |
US20160199361A1 (en) * | 2013-08-19 | 2016-07-14 | Rutgers, The State University Of New Jersey | Method of Inducing An Anti-Retroviral Immune Response By Counter-Acting Retro-Virus Induced Anti-Apoptosis |
US20170239182A1 (en) * | 2014-08-13 | 2017-08-24 | Mark E. Hayes | Pharmaceutical formulations of and methods to prepare chelating agents for efficient metal removal treatment systems |
US20170231910A1 (en) * | 2014-08-13 | 2017-08-17 | Mark E. Hayes | Pharmaceutical formulations of chelating agents as a metal removal treatment system |
US11298364B2 (en) * | 2015-08-31 | 2022-04-12 | The University Of Adelaide | Methods and products for preventing and/or treating microorganism infections comprising iron chelators and non-iron porphyrins |
US10960002B2 (en) | 2016-05-13 | 2021-03-30 | The Brigham And Women's Hospital, Inc. | Volatile metabolite profiles for the diagnosis and treatment of Mucorales fungi |
FR3095755A1 (fr) * | 2019-05-10 | 2020-11-13 | Balmes Transplantation | Nouveaux médicaments cytoprotecteurs |
WO2020264076A1 (en) | 2019-06-28 | 2020-12-30 | The Procter & Gamble Company | Light augmented treatment method |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8329043D0 (en) * | 1983-10-31 | 1983-11-30 | Hider R C | Pharmaceutical compositions |
US4698431A (en) * | 1985-11-12 | 1987-10-06 | The United States Of America As Represented By The United States Department Of Energy | Hydroxypyridonate chelating agents |
TW349870B (en) * | 1993-09-30 | 1999-01-11 | Janssen Pharmaceutica Nv | An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof |
MY129541A (en) | 1996-06-25 | 2007-04-30 | Novartis Ag | Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
WO1999009997A1 (en) * | 1997-08-26 | 1999-03-04 | Board Of Regents, The University Of Texas System | Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections |
DE50111949D1 (de) * | 2000-12-16 | 2007-03-15 | Alstom Technology Ltd | Komponente einer Strömungsmaschine |
GB0223978D0 (en) | 2002-10-15 | 2002-11-20 | Novartis Ag | Organic compound |
ITMI20022447A1 (it) * | 2002-11-19 | 2004-05-20 | Carlo Ghisalberti | Uso di piridinoni nel trattamento della purpura capillare ed affezioni cutanee correlate. |
MXPA05007156A (es) * | 2002-12-31 | 2005-09-21 | Nektar Therapeutics | Formulacion farmaceuticas aerosolizable para terapia para infecciones fungicas. |
WO2004108114A2 (en) * | 2003-03-31 | 2004-12-16 | Dinesh Shantilal Patel | Anti-fungal composition and a process for its manufacture |
DE10356409B4 (de) * | 2003-11-28 | 2006-12-28 | Biofrontera Discovery Gmbh | Neues Arzneimittel Oxachelin und Derivate |
-
2007
- 2007-07-12 CL CL200702026A patent/CL2007002026A1/es unknown
- 2007-07-12 TW TW096125466A patent/TWI448285B/zh not_active IP Right Cessation
- 2007-07-13 WO PCT/US2007/016065 patent/WO2008008537A2/en active Application Filing
- 2007-07-13 NZ NZ574862A patent/NZ574862A/en not_active IP Right Cessation
- 2007-07-13 AU AU2007272781A patent/AU2007272781B2/en not_active Ceased
- 2007-07-13 CA CA002657634A patent/CA2657634A1/en not_active Abandoned
- 2007-07-13 US US12/373,511 patent/US20100129434A1/en not_active Abandoned
- 2007-07-13 JP JP2009519562A patent/JP2009543788A/ja active Pending
- 2007-07-13 EP EP11003922A patent/EP2412371A1/en not_active Withdrawn
- 2007-07-13 BR BRPI0714221-8A patent/BRPI0714221A2/pt not_active IP Right Cessation
- 2007-07-13 SG SG2011075421A patent/SG177122A1/en unknown
- 2007-07-13 EP EP07796874A patent/EP2043636A2/en not_active Withdrawn
- 2007-07-13 RU RU2009104961/15A patent/RU2464024C2/ru not_active IP Right Cessation
- 2007-07-13 KR KR1020097002793A patent/KR20090036587A/ko not_active Application Discontinuation
- 2007-07-13 MX MX2009000506A patent/MX2009000506A/es not_active Application Discontinuation
-
2009
- 2009-01-08 IL IL196389A patent/IL196389A0/en unknown
- 2009-01-12 TN TN2009000004A patent/TN2009000004A1/fr unknown
- 2009-02-04 MA MA31613A patent/MA30625B1/fr unknown
- 2009-02-05 NO NO20090565A patent/NO20090565L/no not_active Application Discontinuation
-
2012
- 2012-11-27 JP JP2012258262A patent/JP2013040212A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
BRPI0714221A2 (pt) | 2013-01-01 |
MA30625B1 (fr) | 2009-08-03 |
TWI448285B (zh) | 2014-08-11 |
SG177122A1 (en) | 2012-01-30 |
CL2007002026A1 (es) | 2008-06-06 |
KR20090036587A (ko) | 2009-04-14 |
EP2043636A2 (en) | 2009-04-08 |
AU2007272781A1 (en) | 2008-01-17 |
US20100129434A1 (en) | 2010-05-27 |
AU2007272781B2 (en) | 2012-10-18 |
TW200816994A (en) | 2008-04-16 |
WO2008008537A3 (en) | 2008-04-24 |
NO20090565L (no) | 2009-03-30 |
IL196389A0 (en) | 2009-09-22 |
JP2013040212A (ja) | 2013-02-28 |
EP2412371A1 (en) | 2012-02-01 |
RU2009104961A (ru) | 2010-08-20 |
JP2009543788A (ja) | 2009-12-10 |
CA2657634A1 (en) | 2008-01-17 |
RU2464024C2 (ru) | 2012-10-20 |
WO2008008537A2 (en) | 2008-01-17 |
NZ574862A (en) | 2012-02-24 |
TN2009000004A1 (en) | 2010-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009000506A (es) | Composiciones y metodos para el tratamiento de la mucormicosis y otras enfermedades micoticas. | |
WO2004078138A3 (en) | Prophylactic treatment of uv-induced epidermal neoplasia | |
MX2007003636A (es) | Composiciones funguicidas. | |
WO2007112000A3 (en) | Treatment of pain | |
CO6511232A2 (es) | Combinaciones fungicidas sinérgicas que contienen una ditiino-tetracarboximida fungicida | |
MX2010008102A (es) | Compuestos fungicidas heterociclicos. | |
MY148424A (en) | Fungicidal azocyclic amides | |
TW200639159A (en) | Treatment of pain | |
MX2019011506A (es) | Inhibicion de cinasa 1 de punto de control (chk1) para el tratamiento de cancer. | |
UA103614C2 (uk) | Лікарський засіб, що містить комбінацію інгібітора кінази та анти-гліпікан 3-антитіла, для лікування раку печінки | |
WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
WO2011047439A8 (en) | Novel parasite therapy | |
MY150682A (en) | Method for using vasopressin antagonist with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival | |
PH12021550832A1 (en) | Combination of small molecule cd-47 inhibitors with other anti-cancer agents | |
MX2021000700A (es) | Composicion farmaceutica para prevenir o tratar esteatohepatitis no alcoholica. | |
MX2019014302A (es) | Agente para prevenir o tratar la ataxia espinocerebelosa. | |
TW200742580A (en) | Methods for treating nephrolithiasis | |
WO2011153458A3 (en) | Compositions and methods for inhibition of or treatment of dengue virus infection | |
WO2007015841A3 (en) | A method for treating preeclampsia | |
TNSN08447A1 (en) | Combination comprising an iron chelator and an anti-neoplastic agent and use thereof | |
WO2002036129A3 (de) | Topische behandlung von mastalgie mit aromatase-hemmern, wie androstendion | |
WO2006101909A3 (en) | Combination therapy for treating or preventing diseases | |
WO2002055022A3 (en) | Active metabolite of antifungal compound | |
UA96736C2 (ru) | Ингибиторы pi3k для лечения эндометриоза | |
TNSN08479A1 (en) | Method of treatment of hereditary hemochromatosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |